Pfizer Terminates Torcetrapib Program

Company will investigate whether an increased risk of mortality is a class effect of CETP inhibitors.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet